白雪,彭扬,李慧,张月,何平

• 1:中国医科大学附属盛京医院

摘要(Abstract)：

目的探讨山楂酸与顺铂合用对肺癌细胞A549增殖及凋亡产生的影响。方法将人的肺癌细胞系A549经过药物干预(山楂酸、顺铂),并将干预后的肺癌细胞通过MTT实验,分析细胞增殖能力变化,通过流式细胞技术,分析细胞的凋亡水平变化。通过Western blot分析细胞中XIAP、Survivin的表达水平变化。结果山楂酸和顺铂合用后,A549细胞的增殖率显著降低,凋亡水平显著提高;荧光电子显微镜下观察到凋亡细胞明显增加,核碎裂明显,细胞大片脱落;Western blot结果显示,山楂酸和顺铂合用,显著下调XIAP、Survivin的蛋白表达量。结论山楂酸和顺铂合用抑制肺癌细胞的增殖,促进肺癌细胞的凋亡,并下调细胞中凋亡抑制相关指标XIAP、Survivin的表达水平。

关键词(KeyWords)： 肺癌;山楂酸;顺铂;增殖;凋亡

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 白雪,彭扬,李慧,张月,何平

DOI: 10.14053/j.cnki.ppcr.201704003

参考文献(References)：

• [1]Hu W,Jin P,Liu W.Periostin contributes to cisplatin resistance in human non-small cell lung cancer A549 cells via activation of stat3 and akt and upregulation of survivin[J].Cell Physiol Biochem,2016,38(3):1199-2008.
• [2]Nascimento AV,Gattacceca F,Singh A,et al.Biodistribution and pharmacokinetics of M ad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models[J].Nanomedicine(Lond),2016,11(7):767-781.
• [3]Okita R,Yukawa T,Nojima Y,et al.MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated w ith good prognosis in patients w ith non-small cell lung cancer[J].Cancer Immunol Immunother,2016,65(5):499-509.
• [4]Miyahara D,Katsuta T,Maehara M,et al.Safety and antitumor effects of docetaxel plus cisplatin in intermediate-and high-risk endometrial cancer[J].Anticancer Res,2016,36(7):3725-3729.
• [5]E Silva PV,da Silva RF,Borges C S,et al.Sexual differentiation and reproductive development of female rat offspring after paternal exposure to the anti-tumor pharmaceutical cisplatin[J].Reprod Toxicol,2016,60:112-122.
• [6]Yang T,Zhao P,Rong Z,et al.Anti-tumor efficiency of lipidcoated cisplatin nanoparticles co-loaded w ith microRNA-375[J].Theranostics,2016,6(1):142-154.
• [7]Mooi LY,Wahab NA,Lajis NH,et al.Chemopreventive properties of phytosterols and maslinic acid extracted from Coleus tuberosus in inhibiting the expression of EBV early-antigen in Raji cells[J].Chem Biodivers,2010,7(5):1267-1275.
• [8]Qian Y,Guan T,Tang X,et al.Maslinic acid,a natural triterpenoid compound from Olea europaea,protects cortical neurons against oxygen-glucose deprivation-induced injury[J].Eur J Pharmacol,2011,670(1):148-153.
• [9]Qiu WW,Shen Q,Yang F,et al.Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B[J].Bioorg M ed Chem Lett,2009,19(23):6618-6622.
• [10]Rufino-Palomares EE,Reyes-Zurita FJ,García-Salguero L,et al.M aslinic acid,a triterpenic anti-tumoural agent,interferes w ith cytoskeleton protein expression in HT29 human coloncancer cells[J].J Proteomics,2013,83:15-25.
• [11]Fukumitsu S,Villareal MO,Fujitsuka T,et al.Anti-inflammatory and anti-arthritic effects of pentacyclic triterpenoids maslinic acid through NF-kappa B inactivation[J].M ol Nutr Food Res,2016,60(2):399-409.
• [12]Huang L,Guan T,Qian Y,et al.Anti-inflammatory effects of maslinic acid,a natural triterpene,in cultured cortical astrocytes via suppression of nuclear factor-kappa B[J].Eur J Pharmacol,2011,672(1-3):169-174.
• [13]Li C,Yang Z,Li Z,et al.Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-kappa B and M APK signaling pathw ays[J].J Bone M iner Res,2011,26(3):644-656.
• [14]Hsum YW,Yew WT,Hong PL,et al.Cancer chemopreventive activity of maslinic acid:suppression of COX-2 expression and inhibition of NF-kappa B and AP-1 activation in Raji cells[J].Planta M ed,2011,77(2):152-157.
• [15]Márquez Martín A,De la Puerta Vázquez R,Fernández-Arche A,et al.Supressive effect of maslinic acid from pomace olive oil on oxidative stress and cytokine production in stimulated murine macrophages[J].Free Radic Res,2006,40(3):295-302.
• [16]Li C,Yang Z,Zhai C,et al.Maslinic acid potentiates the antitumor activity of tumor necrosis factor alpha by inhibiting NFkappa B signaling pathw ay[J].M ol Cancer,2010,9:73.
• [17]Van Der Steen N,Deben C,Deschoolmeester V,et al.Better to be alone than in bad company:the antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer[J].World J Clin Oncol,2016,7(6):425-432.
• [18]杨和平,金润女,苏伟平,等.贝伐单抗联合培美曲塞+顺铂治疗非小细胞肺癌的临床分析[J].临床军医杂志,2015,43(10):1053-1055.
• [19]张潇,赵庆春.601例非小细胞肺癌患者化疗用药分析[J].创伤与急危重病医学,2016,4(3):158-161.
• [20]Tseng CY,Lin CH,Wu LY,et al.Potential combinational anti-cancer therapy in non-small cell lung cancer w ith traditional Chinese medicine Sun-Bai-Pi extract and cisplatin[J].PLo S One,2016,11(5):0155469.
• [21]Kim E,Biswas T,Bakaki P,et al.Comparison of cisplatin/etoposide versus carboplatin/etoposide concurrent chemoradiation therapy for limited-stage small cell lung cancer(LS-SCLC)in the elderly population(age>65 years)using national SEER-Medicare data[J].Pract Radiat Oncol,2016,6(5):e163-e169.
• [22]Ma X,Le Teuff G,Lacas B,et al.Prognostic and predictive effect of TP53 mutations in patients w ith non-small cell lung cancer from adjuvant cisplatin-based therapy randomized trials:a LACE-bio pooled analysis[J].J Thorac Oncol,2016,11(6):850-861.
• [23]Kang JH,Ahn MJ,Kim DW,et al.Tolerability and outcomes of first-line pemetrexed-cisplatin follow ed by gefitinib maintenance therapy versus gefitinib monotherapy in Korean patients w ith advanced nonsquamous non-small cell lung cancer:a post hoc descriptive subgroup analysis of a randomized,phase 3 trial[J].Cancer Res Treat,2016,48(2):458-464.
• [24]周红兵,艾伟,孙林,等.紫杉醇脂质体和吉西他滨分别联合顺铂治疗晚期非小细胞肺癌的效果及其与中性粒细胞/淋巴细胞比值的相关性[J].中国医药,2015,10(4):468-472.
• [25]赵卫刚,胡世莲,丁西平,等.吉西他滨联合顺铂与紫杉醇联合顺铂/卡铂治疗非小细胞肺癌疗效的系统评价[J].实用医学杂志,2016,32(9):1508-1511.
• [26]Gong C,Qian L,Yang H,et al.Hepatotoxicity and pharmacokinetics of cisplatin in combination therapy w ith a traditional Chinese medicine compound of Zengmian Yiliu granules in ICR mice and SKOV-3-bearing nude mice[J].BM C Complement Altern M ed,2015,15:283.
• [27]Zhang QH,Gong C,Yang H,et al.Pharmacokinetics of cisplatin in the absence or presence of zengmian yiliu granules(a traditional Chinese medicine compound)in rats determined via ICP-M S:an investigation on drug-herb interactions[J].Pharm Biol,2015,53(2):159-166.
• [28]Chen Y,Di L,Zhang S,et al.The randomized,multicenter,controlled clinic trial for treating advanced non-small cell lung cancer w ith combined traditional Chinese medicine and vinorelbine(Navelbine,NVB)plus cisplatin(DDP)chemotherapy[J].Zhongguo Fei Ai Za Zhi,2008,11(3):441-444.
• [29]To KK,Au-Yeung SC,Ho YP.Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicineplatinum anticancer agents correlates w ith their chemical reactivity tow ards sulfur-containing nucleophiles[J].Anticancer Drugs,2006,17(6):673-683.
• [30]Rodríguez-Berriguete G,Torrealba N,Ortega MA,et al.Prognostic value of inhibitors of apoptosis proteins(IAPs)and caspases in prostate cancer:caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy[J].BM C Cancer,2015,15:809.
• [31]Carter BZ,Mak DH,Wang Z,et al.XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AM L cells[J].Leuk Res,2013,37(8):974-979.
• [32]Tamm I,Richter S,Scholz F,et al.XIAP expression correlates w ith monocytic differentiation in adult de novo AM L:impact on prognosis[J].Hematol J,2004,5(6):489-495.
• [33]Farrand L,Byun S,Kim JY,et al.Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53,Xlinked inhibitor of apoptosis protein(XIAP),and mitochondrial fission[J].J Biol Chem,2013,288(33):23740-23750.
• [34]Chen F,Sui G,Chen H,et al.The influence of arsenic trioxide combined w ith cisplatin on the grow th and expression of Xlinked inhibitor of apoptosis protein,XIAP of human non-small cell lung cancer cells[J].Zhongguo Fei Ai Za Zhi,2007,10(3):168-171.
• [35]Pyrko P,Soriano N,Kardosh A,et al.Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog,dimethyl-celecoxib(DM C),in tumor cells in vitro and in vivo[J].Mol Cancer,2006,5:19